Domestic pharmaceutical companies win on the formulation patent trial over Cialis

In regards to ‘Cialis,’ the impotency treatment which will be expired in its substance patent on the coming September, the first trial decision has been made against patent challenges of domestic pharmaceutical companies.

As Cialis, a blockbuster pharmaceutical product recoding approximately KRW 25 billion last year, has its patent expiration ahead this September, about 20 domestic pharmaceuti...